Physician profile
Natalie Ring
NPI 1902399074
$1,857.46
in general payments reported to CMS, 2019-2025
8 companies · $448 in 2025
The $448 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $349 · 2023: $303 · 2024: $547 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $697.63 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $388.13 | 2024-2025 | Indigo System, Ruby Coil, Penumbra System |
| Boston Scientific Corporation | $261.32 | 2024-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered, Obsidio |
| Stryker Corporation | $243.53 | 2022-2025 | Spinejack, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Terumo Medical Corporation | $171.92 | 2023-2024 | Azur Cx Detachable, Glidewire |
| Philips North America LLC | $36.77 | 2023 | |
| Imperative Care, INC | $30.87 | 2025 | Symphony Catheter |
| Baylis Medical Technologies INC. | $27.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.